| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 99 |
| 1 | ADALIMUMAB | 97 |
| 2 | RALOXIFENE HYDROCHLORIDE | 94 |
| 3 | METHOTREXATE | 91 |
| 4 | CONJUGATED ESTROGENS | 89 |
| 5 | ESTROGENS, CONJUGATED | 89 |
| 6 | LEVONORGESTREL | 85 |
| 7 | MEDROXYPROGESTERONE ACETATE | 81 |
| 8 | ERGOCALCIFEROL | 80 |
| 9 | RANITIDINE | 79 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTRIOL,ESTRADIOL | 1 | 0.2000 |
| 1 | CLOTRIMAZOLE1% CLOTRIMAZOLE | 1 | 0.0182 |
| 2 | TOREMIFENE CITRATE | 5 | 0.0116 |
| 3 | ESTRADIOL VALERATE | 8 | 0.0103 |
| 4 | RELACORILANT | 1 | 0.0101 |
| 5 | DOSTARLIMAB | 20 | 0.0080 |
| 6 | TAMOXIFEN CITRATE | 45 | 0.0078 |
| 7 | CONJUGATED ESTROGENS/BAZEDOXIFENE | 5 | 0.0053 |
| 8 | BROMOCRIPTINE MESYLATE | 3 | 0.0046 |
| 9 | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | 1 | 0.0040 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 181 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 155 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 152 |
| 3 | Corticosteroid [EPC] | 136 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 91 |
| 5 | Progestin [EPC] | 90 |
| 6 | Progestin-containing Intrauterine System [EPC] | 85 |
| 7 | Provitamin D2 Compound [EPC] | 80 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 73 |
| 9 | Vitamin C [EPC] | 72 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 1 | Estrogen Agonist/Antagonist [EPC] | 8 | 0.0031 |
| 2 | Provitamin D2 Compound [EPC] | 80 | 0.0027 |
| 3 | Androgen [EPC] | 29 | 0.0011 |
| 4 | Estrogen [EPC] | 181 | 0.0010 |
| 5 | Calcitonin [EPC] | 3 | 0.0010 |
| 6 | Blood Viscosity Reducer [EPC] | 4 | 0.0009 |
| 7 | Progesterone [EPC] | 20 | 0.0008 |
| 8 | Progestin Antagonist [EPC] | 4 | 0.0008 |
| 9 | Interleukin-17A Antagonist [EPC] | 30 | 0.0008 |